Stiff-person syndrome following West Nile fever

Archives of Neurology

Volumn 61, Issue 6, 2004, Pages 938-941

  Hassin Baer, Sharon ^a,b   Kirson, Eilon D ^a   Shulman, Lester ^c   Buchman, Aron S ^a,f   Bin, Hanna ^c   Hindiyeh, Musa ^c   Markevich, Lea ^d   Mendelson, Ella ^c,e  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c MINISTRY OF HEALTH   (Israel)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^e BAR ILAN UNIVERSITY   (Israel)

^f RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; EPITOPE; GLUTAMATE DECARBOXYLASE ANTIBODY; VIRUS PROTEIN;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CROSS REACTION; DISEASE ASSOCIATION; GENBANK; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; RARE DISEASE; SEQUENCE HOMOLOGY; STIFF MAN SYNDROME; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

ADULT; AMINO ACID SEQUENCE; AUTOANTIBODIES; GLUTAMATE DECARBOXYLASE; HUMANS; ISOENZYMES; MALE; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; STIFF-PERSON SYNDROME; VIRAL NONSTRUCTURAL PROTEINS; WEST NILE FEVER; WEST NILE VIRUS;

EID: 2942531055     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.6.938     Document Type: Article

References (36)

1. Lorish TR, Thorsteinsson G, Howard FM Jr. Stiff-man syndrome updated. Mayo Clin Proc. 1989;64:629-636.
2. Meinck HM, Thompson PD. Stiff man syndrome and related conditions. Mov Disord. 2002;17:853-866.
3. Warich-Kirches M, Von Bossanyi P, Treuheit T, et al. Stiff-man syndrome: possible autoimmune etiology targeted against GABA-ergic cells. Clin Neuropathol. 1997;16:214-219.
4. Helfgott SM. Stiff-man syndrome: from the bedside to the bench. Arthritis Rheum. 1999;42:1312-1320.
5. Weiss D, Carr D, Kellachan J, et al. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis. 2001;7:654-658.
6. Cernescu C, Ruta SM, Tardei G, et al. A high number of severe neurologic clinical forms during an epidemic of West Nile virus infection. Rom J Virol. 1997;48:13-25.
7. Nisenbaum C, Wallis K. Meningo-encephalitis due to West Nile fever: reports of 2 cases. Helv Paediatr Acta. 1965;20:392-402.
8. Ahmed S, Libman R, Wesson K, Ahmed F, Einberg K. Guillain-Barre syndrome: an unusual presentation of West Nile virus infection. Neurology. 2000;55:144-146.
9. Chowers MY, Lang R, Nassar F, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis. 2001;7:675-678.
10. Siegel-Itzkovich J. Twelve die of West Nile virus in Israel. BMJ. 2000;321:724.
11. Shimoni Z, Niven MJ, Pitlick S, Bulvik S. Treatment of West Nile virus encephalitis with intravenous immunoglobulin [letter]. Emerg Infect Dis. 2001;7:759.
12. Amato AA, Cornman EW, Kissel JT. Treatment of stiff-man syndrome with intravenous immunoglobulin. Neurology. 1994;44:1652-1654.
13. Barker RA, Marsden CD. Successful treatment of stiff man syndrome with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry. 1997;62:426-427.
14. Karlson EW, Sudarsky L, Ruderman E, Pierson S, Scott M, Helfgott SM. Treatment of stiff-man syndrome with intravenous immune globulin. Arthritis Rheum. 1994;37:915-918.
15. Khanlou H, Eiger G. Long-term remission of refractory stiff-man syndrome after treatment with intravenous immunoglobulin. Mayo Clin Proc. 1999;74:1231-1232.
16. Roehrig JT, Nash D, Maldin B, et al. Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West-Nile virus encephalitis cases. Emerg Infect Dis. 2003;9:376-379.
17. Gunther G, Haglund M, Lindquist L, Skoldenberg B, Forsgren M. Intrathecal IgM, IgA and IgG antibody response in tick-borne encephalitis: long-term follow-up related to clinical course and outcome. Clin Diagn Virol. 1997;8:17-29.
18. Sejvar JJ, Haddad MB, Tierney BC, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA. 2003;290:511-515.
19. Schneider-Schaulies J, Dorries R, Meulen VT. Establishment and control of viral infections of the central nervous system. In: Keane RW, Hickey WF, eds. Immunology of the Nervous System. New York, NY: Oxford University Press Inc; 1997:576-610.
20. Mathur A, Arora KL, Rawat S, Chaturvedi UC. Persistence, latency and reactivation of Japanese encephalitis virus infection in mice. J Gen Virol. 1986;67(pt 2): 381-385.
21. Komar N, Langevin S, Hinten S, et al. Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg Infect Dis. 2003;9:311-322.
22. Brinton MA. Isolation of a replication-efficient mutant of West Nile virus from a persistently infected genetically resistant mouse cell culture. J Virol. 1981;39:413-421.
23. Dalakas MC, Fujii M, Li M, McElroy B. The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology. 2000;55:1531-1535.
24. Hyoty H. Enterovirus infections and type 1 diabetes. Ann Med. 2002;34:138-147.
25. Requena I, Arias M, Pardo J, Portela M, Alvarez JA. Syndromes of continuous muscular activity: report of a central case (stiff-man) and a peripheral case (neuromyotonia) associated with neuroborreliosis [in Spanish]. Rev Neurol. 1995;23:129-133.
26. Martin R, Meinck HM, Schulte-Mattler W, Ricker K, Mertens HG. Borrelia burgdorferi myelitis presenting as a partial stiff man syndrome. J Neurol 1990;237:51-54.
27. Lannuzel A, Hermann C, Yousry C, Lees A, Caparros-Lefebvre D. Encephalomyelitis with rigidity complicating human immunodeficiency virus infection. Mov Disord. 2002;17:202-204.
28. Bolay H, Soylemezoglu F, Nurlu G, Tuncer S, Varli K. PCR detected hepatitis C virus genome in the brain of a case with progressive encephalomyelitis with rigidity. Clin Neurol Neurosurg. 1996;98:305-308.
29. Blum P, Jankovic J. Stiff-person syndrome: an autoimmune disease. Mov Disord. 1991;6:12-20.
30. Meinck HM. Stiff man syndrome. CNS Drugs. 2001;15:515-526.
31. Brashear HR, Phillips LH 2nd. Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome. Neurology. 1991;41:1588-1592.
32. Fogan L. Progressive encephalomyelitis with rigidity responsive to plasmapheresis and immunosuppression. Ann Neurol. 1996;40:451-453.
33. Shariatmadar S, Noto TA. Plasma exchange in stiff-man syndrome. TherApher. 2001;5:64-67.
34. Vicari AM, Folli F, Pozza G, et al. Plasmapheresis in the treatment of stiff-man syndrome [letter]. N Engl J Med. 1989;320:1499.
35. Dalakas MC, Fujii M, Li M, Lutfi B, Kyhos J, McElroy B. High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med. 2001;345:1870-1876.
36. Tong JC, Myers MA, Mackay IR, Zimmet PZ, Rowley MJ. The PEVKEK region of the pyridoxal phosphate binding domain of GAD65 expresses a dominant B cell epitope for type 1 diabetes sera. Ann N Y Acad Sci. 2002;958:182-189.